Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXCM DexCom	$79.84 -0.2%	$80.33	$57.52 ▼ $117.19	$31.37B	1.46	4.34 million shs	5.67 million shs
GMED Globus Medical	$57.82 -0.1%	$63.60	$54.48 ▼ $94.93	$7.83B	1.2	1.11 million shs	1.27 million shs
PODD Insulet	$307.67 +1.5%	$292.91	$173.00 ▼ $329.33	$21.33B	1.37	714,753 shs	1.17 million shs
STE STERIS	$236.95 +0.5%	$234.89	$200.98 ▼ $252.79	$23.18B	0.94	547,081 shs	430,320 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXCM DexCom	-0.20%	-3.81%	-5.53%	+8.55%	-31.55%
GMED Globus Medical	+0.04%	-1.85%	-1.99%	-24.56%	-13.07%
PODD Insulet	+1.49%	+0.35%	-4.26%	+12.82%	+50.74%
STE STERIS	+0.63%	-1.69%	-2.57%	+6.94%	+8.63%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DXCM DexCom	4.7985 of 5 stars	3.5	5.0	0.0	4.7	2.1	2.5	1.9
GMED Globus Medical	4.7337 of 5 stars	4.3	3.0	0.0	4.1	1.4	2.5	1.9
PODD Insulet	4.3382 of 5 stars	2.4	5.0	0.0	4.9	2.3	0.8	1.9
STE STERIS	4.8809 of 5 stars	3.3	5.0	3.3	3.8	2.8	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DXCM DexCom	2.95	Moderate Buy	$98.50	23.37% Upside
GMED Globus Medical	2.62	Moderate Buy	$94.00	62.57% Upside
PODD Insulet	2.83	Moderate Buy	$321.00	4.33% Upside
STE STERIS	2.63	Moderate Buy	$263.83	11.35% Upside

Current Analyst Ratings Breakdown

Latest GMED, DXCM, STE, and PODD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	DXCM DexCom	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$102.00
6/16/2025	PODD Insulet	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$365.00
6/10/2025	GMED Globus Medical	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
5/30/2025	DXCM DexCom	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$104.00
5/30/2025	PODD Insulet	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$380.00
5/29/2025	STE STERIS	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$263.00
5/27/2025	GMED Globus Medical	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
5/27/2025	GMED Globus Medical	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
5/27/2025	PODD Insulet	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$328.00 ➝ $360.00
5/22/2025	DXCM DexCom	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$82.00 ➝ $102.00
5/22/2025	PODD Insulet	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$320.00 ➝ $380.00

(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DXCM DexCom	$4.03B	7.76	$2.24 per share	35.59	$5.38 per share	14.84
GMED Globus Medical	$2.52B	3.11	$6.65 per share	8.69	$30.40 per share	1.90
PODD Insulet	$2.20B	9.85	$4.50 per share	68.33	$17.27 per share	17.82
STE STERIS	$5.46B	4.27	$14.33 per share	16.53	$67.33 per share	3.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DXCM DexCom	$576.20M	$1.34	59.58	32.46	1.71	12.90%	30.05%	10.00%	7/24/2025 (Estimated)
GMED Globus Medical	$102.98M	$1.34	43.15	14.35	1.68	7.39%	10.52%	8.56%	8/5/2025 (Estimated)
PODD Insulet	$418.30M	$5.56	55.34	61.91	2.71	18.29%	22.25%	8.29%	8/6/2025 (Estimated)
STE STERIS	$614.64M	$6.20	38.22	23.86	N/A	11.26%	14.21%	9.13%	8/5/2025 (Estimated)

Latest GMED, DXCM, STE, and PODD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/14/2025	Q4 2025	STE STERIS	$2.59	$2.74	+$0.15	$1.47	$1.47 billion	$1.48 billion
5/8/2025	Q1 2025	GMED Globus Medical	$0.74	$0.68	-$0.06	$0.54	$629.74 million	$598.12 million
5/8/2025	Q1 2025	PODD Insulet	$0.81	$1.02	+$0.21	$0.50	$543.20 million	$569.00 million
5/1/2025	Q1 2025	DXCM DexCom	$0.33	$0.32	-$0.01	$0.27	$1.02 billion	$1.04 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DXCM DexCom	N/A	N/A	N/A	N/A	N/A
GMED Globus Medical	N/A	N/A	N/A	N/A	N/A
PODD Insulet	N/A	N/A	N/A	N/A	N/A
STE STERIS	$2.28	0.96%	N/A	36.77%	20 Years

Latest GMED, DXCM, STE, and PODD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/7/2025	STE STERIS	quarterly	$0.57	1.01%	6/10/2025	6/10/2025	6/26/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DXCM DexCom	0.55	1.50	1.32
GMED Globus Medical	N/A	4.45	2.72
PODD Insulet	1.21	4.47	3.63
STE STERIS	0.29	1.96	1.39

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DXCM DexCom	97.75%
GMED Globus Medical	95.16%
PODD Insulet	N/A
STE STERIS	94.69%

Insider Ownership

Company	Insider Ownership
DXCM DexCom	0.32%
GMED Globus Medical	18.54%
PODD Insulet	0.39%
STE STERIS	1.07%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DXCM DexCom	10,300	392.11 million	390.85 million	Optionable
GMED Globus Medical	5,300	135.38 million	110.28 million	Optionable
PODD Insulet	3,900	70.38 million	70.10 million	Optionable
STE STERIS	17,787	98.37 million	97.32 million	Optionable

GMED, DXCM, STE, and PODD Headlines

Recent News About These Companies

GHP Investment Advisors Inc. Acquires 2,186 Shares of STERIS plc (NYSE:STE)

June 24 at 5:20 AM | marketbeat.com

STERIS Awarded $450M DLA Patient Monitoring, Capital Equipment Contract Modification

June 23 at 7:58 AM | govconwire.com

Steris secures $450M Navy contract modification

June 23 at 7:58 AM | msn.com

Envestnet Portfolio Solutions Inc. Has $2.17 Million Holdings in STERIS plc (NYSE:STE)

June 23 at 3:52 AM | marketbeat.com

STERIS (STE) Secures $450M Contract Extension for Military Support

June 23 at 3:19 AM | gurufocus.com

STERIS plc (NYSE:STE) Stake Boosted by Harvey Investment Co. LLC

June 22 at 5:59 AM | marketbeat.com

Running Oak Capital LLC Purchases 7,183 Shares of STERIS plc (NYSE:STE)

June 22 at 5:05 AM | marketbeat.com

QRG Capital Management Inc. Purchases 1,559 Shares of STERIS plc (NYSE:STE)

June 22 at 3:42 AM | marketbeat.com

Steris awarded $450M Navy contract modification

June 20, 2025 | msn.com

STERIS Secures $450M DoD Contract Extension for Medical Equipment

June 20, 2025 | econotimes.com

Steris discloses pay for top executives and its median employee

June 20, 2025 | medicaldesignandoutsourcing.com

Biodefense Industry Research 2025-2030 | STERIS, ASP, Ushio, Sotera Health, and Bioquell Lead Market with Broad-Sector Connectivity and Robust Global Distribution Networks

June 20, 2025 | uk.finance.yahoo.com

Riverwater Partners LLC Lowers Position in STERIS plc (NYSE:STE)

June 20, 2025 | marketbeat.com

STERIS plc (NYSE:STE) Shares Purchased by Boston Trust Walden Corp

June 19, 2025 | marketbeat.com

Harrell Investment Partners LLC Sells 1,175 Shares of STERIS plc (NYSE:STE)

June 19, 2025 | marketbeat.com

Are Investors Undervaluing STERIS plc (NYSE:STE) By 40%?

June 18, 2025 | finance.yahoo.com

STERIS Stock: Is STE Outperforming the Healthcare Sector?

June 18, 2025 | finance.yahoo.com

STERIS plc (NYSE:STE) Shares Sold by Assenagon Asset Management S.A.

June 18, 2025 | marketbeat.com

STERIS plc (NYSE:STE) Shares Sold by Mn Services Vermogensbeheer B.V.

June 17, 2025 | marketbeat.com

STERIS plc (NYSE:STE) Receives Consensus Recommendation of "Moderate Buy" from Analysts

June 17, 2025 | marketbeat.com

Vaughan Nelson Investment Management L.P. Raises Stake in STERIS plc (NYSE:STE)

June 16, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why Goldman Sachs Suddenly Boosted These 3 Trucking Stocks
By Gabriel Osorio-Mazilli | June 9, 2025
View Why Goldman Sachs Suddenly Boosted These 3 Trucking Stocks
Archer Aviation Stock Steadies After Short-Seller Report
By Jeffrey Neal Johnson | May 30, 2025
View Archer Aviation Stock Steadies After Short-Seller Report
More Than a Monetary Metal: Silver's Case for Outperformance
By Jeffrey Neal Johnson | June 22, 2025
View More Than a Monetary Metal: Silver's Case for Outperformance
Tankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names
By Leo Miller | June 10, 2025
View Tankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names
Top 3 Silver Picks to Watch as Bull Market Gains Steam
By Chris Markoch | June 18, 2025
View Top 3 Silver Picks to Watch as Bull Market Gains Steam

GMED, DXCM, STE, and PODD Company Descriptions

DexCom NASDAQ:DXCM

$79.84 -0.16 (-0.20%)

Closing price 06/23/2025 04:00 PM Eastern

Extended Trading

$80.63 +0.79 (+0.99%)

As of 05:31 AM Eastern

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Globus Medical NYSE:GMED

$57.82 -0.05 (-0.08%)

Closing price 06/23/2025 03:59 PM Eastern

Extended Trading

$57.87 +0.05 (+0.08%)

As of 05:43 AM Eastern

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Insulet NASDAQ:PODD

$307.67 +4.52 (+1.49%)

Closing price 06/23/2025 04:00 PM Eastern

Extended Trading

$312.24 +4.57 (+1.49%)

As of 04:38 AM Eastern

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

STERIS NYSE:STE

$236.95 +1.28 (+0.54%)

Closing price 06/23/2025 03:59 PM Eastern

Extended Trading

$236.86 -0.09 (-0.04%)

As of 06/23/2025 04:53 PM Eastern

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time